These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. In silico designing of novel epitope-based peptide vaccines against HIV-1. Heidarnejad F; Namvar A; Sadat SM; Pordanjani PM; Rezaei F; Namdari H; Arjmand S; Bolhassani A Biotechnol Lett; 2024 Jun; 46(3):315-354. PubMed ID: 38403788 [TBL] [Abstract][Full Text] [Related]
6. Comparative analysis of two HIV-1 multiepitope polypeptides for stimulation of immune responses in BALB/c mice. Kardani K; Hashemi A; Bolhassani A Mol Immunol; 2020 Mar; 119():106-122. PubMed ID: 32007753 [TBL] [Abstract][Full Text] [Related]
7. In Silico Design and Immunological Studies of Two Novel Multiepitope DNA-Based Vaccine Candidates Against High-Risk Human Papillomaviruses. Kayyal M; Bolhassani A; Noormohammadi Z; Sadeghizadeh M Mol Biotechnol; 2021 Dec; 63(12):1192-1222. PubMed ID: 34308516 [TBL] [Abstract][Full Text] [Related]
8. Design and in vitro delivery of HIV-1 multi-epitope DNA and peptide constructs using novel cell-penetrating peptides. Davoodi S; Bolhassani A; Sadat SM; Irani S Biotechnol Lett; 2019 Nov; 41(11):1283-1298. PubMed ID: 31531750 [TBL] [Abstract][Full Text] [Related]
9. Prioritization of potential vaccine candidates and designing a multiepitope-based subunit vaccine against multidrug-resistant Salmonella Typhi str. CT18: A subtractive proteomics and immunoinformatics approach. Chand Y; Singh S Microb Pathog; 2021 Oct; 159():105150. PubMed ID: 34425197 [TBL] [Abstract][Full Text] [Related]
10. Cytolytic T lymphocytes (CTLs) from HIV-1 subtype C-infected Indian patients recognize CTL epitopes from a conserved immunodominant region of HIV-1 Gag and Nef. Thakar MR; Bhonge LS; Lakhashe SK; Shankarkumar U; Sane SS; Kulkarni SS; Mahajan BA; Paranjape RS J Infect Dis; 2005 Sep; 192(5):749-59. PubMed ID: 16088824 [TBL] [Abstract][Full Text] [Related]
11. Cross-clade protection induced by human immunodeficiency virus-1 DNA immunogens expressing consensus sequences of multiple genes and epitopes from subtypes A, B, C, and FGH. Malm M; Rollman E; Ustav M; Hinkula J; Krohn K; Wahren B; Blazevic V Viral Immunol; 2005; 18(4):678-88. PubMed ID: 16359234 [TBL] [Abstract][Full Text] [Related]
12. Immunostimulatory effects of Hsp70 fragments and Hsp27 in design of novel HIV-1 vaccine formulations. Milani A; Akbari E; Pordanjani PM; Jamshidi F; Ghayoumi S; Sadeghi SA; Bolhassani A HIV Med; 2024 Feb; 25(2):276-290. PubMed ID: 37936563 [TBL] [Abstract][Full Text] [Related]
13. Delivery of HIV-1 Polyepitope Constructs Using Cationic and Amphipathic Cell Penetrating Peptides into Mammalian Cells. Namazi F; Bolhassani A; Sadat SM; Irani S Curr HIV Res; 2019; 17(6):408-428. PubMed ID: 31755394 [TBL] [Abstract][Full Text] [Related]
14. A synergistic effect of a combined bivalent DNA-protein anti-HIV-1 vaccine containing multiple T- and B-cell epitopes of HIV-1 proteins. Bazhan SI; Karpenko LI; Lebedev LR; Uzhachenko RV; Belavin PA; Eroshkin AM; Ilyichev AA Mol Immunol; 2008 Feb; 45(3):661-9. PubMed ID: 17869341 [TBL] [Abstract][Full Text] [Related]
15. In silico analysis of transmembrane protein 31 (TMEM31) antigen to design novel multiepitope peptide and DNA cancer vaccines against melanoma. Safavi A; Kefayat A; Abiri A; Mahdevar E; Behnia AH; Ghahremani F Mol Immunol; 2019 Aug; 112():93-102. PubMed ID: 31079006 [TBL] [Abstract][Full Text] [Related]
16. Broad and cross-clade CD4+ T-cell responses elicited by a DNA vaccine encoding highly conserved and promiscuous HIV-1 M-group consensus peptides. Almeida RR; Rosa DS; Ribeiro SP; Santana VC; Kallás EG; Sidney J; Sette A; Kalil J; Cunha-Neto E PLoS One; 2012; 7(9):e45267. PubMed ID: 23028895 [TBL] [Abstract][Full Text] [Related]
17. In Silico Design and Immunologic Evaluation of HIV-1 p24-Nef Fusion Protein to Approach a Therapeutic Vaccine Candidate. Larijani MS; Sadat SM; Bolhassani A; Pouriayevali MH; Bahramali G; Ramezani A Curr HIV Res; 2018; 16(5):322-337. PubMed ID: 30605062 [TBL] [Abstract][Full Text] [Related]
19. Expression and immunogenicity of sequence-modified human immunodeficiency virus type 1 subtype B pol and gagpol DNA vaccines. zur Megede J; Otten GR; Doe B; Liu H; Leung L; Ulmer JB; Donnelly JJ; Barnett SW J Virol; 2003 Jun; 77(11):6197-207. PubMed ID: 12743276 [TBL] [Abstract][Full Text] [Related]
20. Marked epitope- and allele-specific differences in rates of mutation in human immunodeficiency type 1 (HIV-1) Gag, Pol, and Nef cytotoxic T-lymphocyte epitopes in acute/early HIV-1 infection. Brumme ZL; Brumme CJ; Carlson J; Streeck H; John M; Eichbaum Q; Block BL; Baker B; Kadie C; Markowitz M; Jessen H; Kelleher AD; Rosenberg E; Kaldor J; Yuki Y; Carrington M; Allen TM; Mallal S; Altfeld M; Heckerman D; Walker BD J Virol; 2008 Sep; 82(18):9216-27. PubMed ID: 18614631 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]